BioCentury | Apr 25, 2011
Clinical News

Aflunov regulatory update

...In November, the European Commission approved Aflunov vaccine from Novartis to prevent influenza A (H5N1) virus...
...clinical practice (GCP) (see BioCentury, June 23, 2008). Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Product: Aflunov...
BioCentury | Oct 4, 2010
Clinical News

Aflunov regulatory update

...CHMP issued a positive opinion recommending approval of an MAA from Novartis for Aflunov H5N1 pre-pandemic...
...is part of the European Medicines Agency (EMA). Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Product: Aflunov...
BioCentury | May 4, 2009
Product Development

Opportunity in Crisis

...Novartis is conducting Phase II trials of an H5N1 vaccine called Aflunov . Like FLuad, Aflunov...
...reported in the Proceedings of the National Academy of Sciences that a single dose of Aflunov...
BioCentury | Jan 26, 2009
Company News

Novartis, U.S. Department of Health and Human Services infectious news

...of the cost, with the pharma responsible for the remainder. Novartis withdrew an MAA for Aflunov...
...H5N1 pre- pandemic influenza vaccine in 2008 in order to conduct additional CHMP-requested clinical trials. Aflunov...
BioCentury | Sep 29, 2008
Clinical News

MF59: Phase I data

...Specifically, in 24 patients who were primed at least 6 years prior to administration of Aflunov...
...variants tested, as well as to the original antigen. Patients were administered 2 doses of Aflunov...
...were presented at the European Influenza Conference in Vilamoura, Portugal. Novartis withdrew an MAA for Aflunov...
BioCentury | Jul 7, 2008
Finance

2Q approvals

...Act-Earli-AD trial to treat mild Alzheimer’s disease (AD) Novartis (NYSE:NVS; SWX:NOVN) Withdraws an MAA for Aflunov...
BioCentury | Jun 23, 2008
Clinical News

Aflunov regulatory update

...EMEA said Novartis withdrew an MAA for Aflunov H5N1 pre- pandemic influenza vaccine to prevent H5N1...
...clinical data but would not disclose a timeline. Novartis AG (NYSE:NVS; SWX:NOVN), Basel, Switzerland Product: Aflunov...
BioCentury | Jun 17, 2008
Company News

Novartis withdraws Aflunov MAA

...The EMEA said Novartis (NYSE:NVS; SWX:NOVN) withdrew an MAA for Aflunov H5N1 pre-pandemic influenza vaccine to...
BioCentury | Jan 7, 2008
Finance

Approval watch

...NexMed (TSX:NEXM)/Warner Chilcott (NASDAQ:WCRX) Befar alprostadil Erectile dysfunction (ED) FDA action 3Q08 Novartis (NYSE:NVS; SWX:NOVN) Aflunov...
Items per page:
1 - 9 of 9